Cargando…
Lapachol inhibits glycolysis in cancer cells by targeting pyruvate kinase M2
Reliance on aerobic glycolysis is one of the hallmarks of cancer. Although pyruvate kinase M2 (PKM2) is a key mediator of glycolysis in cancer cells, lack of selective agents that target PKM2 remains a challenge in exploiting metabolic pathways for cancer therapy. We report that unlike its structura...
Autores principales: | Shankar Babu, Mani, Mahanta, Sailendra, Lakhter, Alexander J., Hato, Takashi, Paul, Subhankar, Naidu, Samisubbu R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796696/ https://www.ncbi.nlm.nih.gov/pubmed/29394289 http://dx.doi.org/10.1371/journal.pone.0191419 |
Ejemplares similares
-
Ferroxitosis: A cell death from modulation of oxidative phosphorylation and PKM2-dependent glycolysis in melanoma
por: Lakhter, Alexander J., et al.
Publicado: (2014) -
Shikonin Inhibits Tumor Growth in Mice by Suppressing Pyruvate Kinase M2-mediated Aerobic Glycolysis
por: Zhao, Xiaoyue, et al.
Publicado: (2018) -
Chloroquine Promotes Apoptosis in Melanoma Cells by Inhibiting BH3 domain Mediated PUMA Degradation
por: Lakhter, Alexander J, et al.
Publicado: (2013) -
Pyruvate Kinase M2 Mediates Glycolysis Contributes to Psoriasis by Promoting Keratinocyte Proliferation
por: Liu, Yun-zi, et al.
Publicado: (2021) -
Aerobic Glycolysis in the Retina: Functional Roles of Pyruvate Kinase Isoforms
por: Rajala, Raju V. S.
Publicado: (2020)